Monder C, Bradlow H L, Zumoff B
J Clin Endocrinol Metab. 1980 Aug;51(2):312-5. doi: 10.1210/jcem-51-2-312.
The role of steroid-17-aldols, 20 beta-isocortisol (11 beta, 17,20 beta-trihydroxy-3-oxo-pregn-4-en-21-al) or 20 beta-iso THE (3 alpha,17,20 beta-trihydroxy-11-oxo-pregnan-21-al), as preferred intermediates for the biosynthesis of cortoic acids was studied in human subjects. The results demonstrated that the isosteroids were converted moe efficiently than cortisol to cortoic acids and hexahydro neutral metabolites. In all cases, the oxidation state at C-11 was largely conserved. After the administration of the 20 beta compounds both 20 alpha and 20 beta epimers of the acidic and neutral metabolites were isolated. This inversion occurred without oxidation at C-20 and provided evidence for the mediation of an epimerase in this transformation. The results further indicate that reversion of the isosteroids to ketolic intermediates (i.e. cortisol, tetrahydrocortisol, and tetrahydrocortisone did not occur.
在人体中研究了甾体-17-醇、20β-异皮质醇(11β,17,20β-三羟基-3-氧代-孕-4-烯-21-醛)或20β-异THE(3α,17,20β-三羟基-11-氧代-孕烷-21-醛)作为皮质酸生物合成的优选中间体的作用。结果表明,与皮质醇相比,这些异甾体更有效地转化为皮质酸和六氢中性代谢物。在所有情况下,C-11位的氧化态基本保持不变。给予20β化合物后,分离出酸性和中性代谢物的20α和20β差向异构体。这种转化在C-20位未发生氧化的情况下发生,为该转化过程中差向异构酶的介导作用提供了证据。结果还表明,异甾体不会逆转为酮醇中间体(即皮质醇、四氢皮质醇和四氢可的松)。